Source: Reuters BY OLIVIA ORAN AND CARL O'DONNELL Valeant Pharmaceuticals International Inc (VRX.TO) has brought in investment banks to review its options amid interest from buyout firms and other companies in a number of its businesses, according to people familiar with the matter. While Valeant has not decided to sell…...